ESCCardiology2021Updated 2021

ESC/EACTS Guidelines for the Management of Valvular Heart Disease 2021

Published by European Society of Cardiology · 96 pages · Class I–II

Low-riskTAVI expansion

Class IIaTEER for sMR

MandatoryHeart Team

Summary

Free preview

Updated recommendations expand TAVI (TAVR) indications to lower-risk patients, with Heart Team decision mandatory. Transcatheter edge-to-edge repair (TEER) recommended for secondary MR in symptomatic patients with HFrEF. Anticoagulation strategy post-TAVI updated with VKA or NOAC depending on indication.

Valvular Heart DiseaseTAVIAortic stenosisMitral regurgitationTEERHeart Team

Key Recommendations

Evidence Grading & Drug Doses

What's New vs Previous Version

Implementation & Clinical Pearls

Full guideline access requires an account

Create a free Prognia account to read the complete guideline — including all recommendations, evidence tables, drug dosing, and clinical pearls.

Full guideline text with all recommendations

Evidence grades (Class I/II/III, Level A/B/C)

AI-generated summary and clinical pearls

Auto-logged as CPD/CME activity

Create Free Account — Instant Access Sign In

Free plan includes 10 guideline reads per day · No credit card required

Loading your page…